PACLITAXEL

PACLITAXEL was reported 101249 times

PACLITAXEL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 COMPUTERISED TOMOGRAM THORAX 39 0.6500
1 PSEUDOCIRRHOSIS 139 0.4187
2 UROGENITAL FISTULA 65 0.2743
3 PIK3CA-ACTIVATED MUTATION 89 0.2681
4 CERVIX CARCINOMA RECURRENT 46 0.2584
5 NAIL TOXICITY 71 0.2367
6 IMMUNE-MEDIATED HYPERTHYROIDISM 58 0.2283
7 IMMUNE-MEDIATED ADRENAL INSUFFICIENCY 179 0.2246
8 HER2 POSITIVE BREAST CANCER 72 0.1920
9 BILIARY TRACT INFECTION 111 0.1785
10 IMMUNE-MEDIATED HYPOTHYROIDISM 183 0.1622
11 HEPATIC ATROPHY 70 0.1562
12 IMMUNE-MEDIATED DERMATITIS 156 0.1548
13 IMMUNE-MEDIATED HYPOPHYSITIS 64 0.1419
14 IMMUNE-MEDIATED PANCREATITIS 52 0.1365
15 RADIATION OESOPHAGITIS 50 0.1312
16 IMMUNE-MEDIATED LUNG DISEASE 238 0.1304
17 METASTASES TO THE MEDIASTINUM 53 0.1286
18 IMMUNE-MEDIATED HEPATITIS 260 0.1272
19 METASTASES TO SKIN 130 0.1258
20 IMMUNE-MEDIATED HEPATIC DISORDER 245 0.1255
21 DELUSION OF GRANDEUR 56 0.1247
22 CYSTOID MACULAR OEDEMA 233 0.1235
23 COMPUTERISED TOMOGRAM THORAX ABNORMAL 82 0.1194
24 PERIPHERAL SENSORY NEUROPATHY 696 0.1190
25 GLUCOCORTICOID DEFICIENCY 50 0.1182
26 PANCREATIC CARCINOMA METASTATIC 334 0.1173
27 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 102 0.1162
28 TRIPLE NEGATIVE BREAST CANCER 76 0.1129
29 IMMUNE-MEDIATED THYROIDITIS 55 0.1113
30 IMMUNE-MEDIATED RENAL DISORDER 46 0.1111
31 ONYCHOLYSIS 171 0.1093
32 IMMUNE-MEDIATED ENCEPHALITIS 57 0.1078
33 HEART FAILURE WITH REDUCED EJECTION FRACTION 57 0.1065
34 MYELOSUPPRESSION 3829 0.1062
35 INFUSION RELATED HYPERSENSITIVITY REACTION 63 0.1048
36 METASTASES TO PLEURA 109 0.1039
37 BRONCHOPLEURAL FISTULA 39 0.1037
38 IMMUNE-MEDIATED NEPHRITIS 48 0.1023
39 BILIARY SEPSIS 46 0.0994
40 MYOCARDIAL INJURY 111 0.0987
41 METASTASES TO PERITONEUM 242 0.0957
42 RADIATION PNEUMONITIS 205 0.0957
43 OVARIAN CANCER METASTATIC 81 0.0953
44 IMMUNE-MEDIATED ENTEROCOLITIS 341 0.0926
45 ACUTE PROMYELOCYTIC LEUKAEMIA 95 0.0924
46 ENTEROCOLITIS INFECTIOUS 83 0.0899
47 OVARIAN CANCER RECURRENT 139 0.0864
48 IMMUNE-MEDIATED MYOCARDITIS 137 0.0848
49 RECALL PHENOMENON 70 0.0837
50 NON-SMALL CELL LUNG CANCER 394 0.0822
51 METASTASES TO MENINGES 180 0.0791
52 LYMPHANGIOSIS CARCINOMATOSA 82 0.0787
53 PERIPHERAL MOTOR NEUROPATHY 108 0.0770
54 BREAST CANCER METASTATIC 827 0.0769
55 GRANULOCYTE COUNT DECREASED 142 0.0765
56 NAIL DYSTROPHY 42 0.0750
57 ALVEOLITIS 104 0.0736
58 HAEMATOTOXICITY 694 0.0730
59 TUMOUR NECROSIS 77 0.0728
60 SUPERIOR VENA CAVA SYNDROME 44 0.0728
61 NON-SMALL CELL LUNG CANCER METASTATIC 63 0.0717
62 POLYNEUROPATHY 849 0.0708
63 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 88 0.0706
64 DILATED CARDIOMYOPATHY 70 0.0692
65 METASTASES TO LIVER 1190 0.0676
66 AORTITIS 46 0.0671
67 METASTASES TO LYMPH NODES 450 0.0666
68 GASTROINTESTINAL PERFORATION 273 0.0656
69 RADIATION SKIN INJURY 76 0.0655
70 SKIN TOXICITY 369 0.0652
71 METASTASES TO BONE 1059 0.0645
72 METASTASES TO LUNG 745 0.0644
73 CARBOHYDRATE ANTIGEN 15-3 INCREASED 49 0.0644
74 HYPOPHYSITIS 129 0.0641
75 HYPOPITUITARISM 111 0.0638
76 BREAST CANCER RECURRENT 198 0.0626
77 THERAPY PARTIAL RESPONDER 937 0.0600
78 METASTASES TO CENTRAL NERVOUS SYSTEM 754 0.0584
79 FULMINANT TYPE 1 DIABETES MELLITUS 60 0.0582
80 SENSE OF OPPRESSION 68 0.0578
81 BILE DUCT STENOSIS 69 0.0575
82 FEBRILE NEUTROPENIA 3785 0.0570
83 LICHENOID KERATOSIS 129 0.0564
84 SUBCLAVIAN VEIN THROMBOSIS 63 0.0553
85 CHOLANGITIS 343 0.0553
86 ANASTOMOTIC LEAK 38 0.0548
87 HYPERSENSITIVITY PNEUMONITIS 62 0.0544
88 FEMALE GENITAL TRACT FISTULA 93 0.0544
89 CAPILLARY LEAK SYNDROME 111 0.0536
90 MALIGNANT ASCITES 41 0.0535
91 SQUAMOUS CELL CARCINOMA OF LUNG 41 0.0535
92 GASTROINTESTINAL TOXICITY 257 0.0534
93 TUMOUR PSEUDOPROGRESSION 58 0.0530
94 ADENOCARCINOMA PANCREAS 67 0.0521
95 MALIGNANT PLEURAL EFFUSION 88 0.0521
96 PNEUMONITIS 1395 0.0512
97 IMMUNE-MEDIATED ADVERSE REACTION 78 0.0508
98 LYMPHOCYTE COUNT ABNORMAL 57 0.0506
99 SMALL INTESTINAL PERFORATION 95 0.0506
100 NEUTROPENIC SEPSIS 360 0.0504
101 FEBRILE INFECTION 59 0.0501
102 NEUTROPHIL COUNT DECREASED 2045 0.0501
103 METASTASES TO ADRENALS 46 0.0498
104 LYMPHADENOPATHY MEDIASTINAL 94 0.0490
105 INVASIVE DUCTAL BREAST CARCINOMA 133 0.0489
106 DEVICE RELATED THROMBOSIS 48 0.0487
107 NEUROTOXICITY 828 0.0472
108 HYPERTRANSAMINASAEMIA 328 0.0471
109 MUCOSAL INFLAMMATION 1232 0.0470
110 TUMOUR HAEMORRHAGE 134 0.0469
111 CHOLANGITIS SCLEROSING 95 0.0462
112 NEUTROPENIC COLITIS 94 0.0454
113 PULMONARY TOXICITY 321 0.0453
114 INFECTIOUS PLEURAL EFFUSION 68 0.0446
115 THYROIDITIS 134 0.0446
116 MALIGNANT NEOPLASM PROGRESSION 4514 0.0440
117 DUODENAL PERFORATION 43 0.0438
118 CARDIAC DYSFUNCTION 163 0.0438
119 NEUROPATHY PERIPHERAL 4100 0.0431
120 ACUTE MYELOID LEUKAEMIA 668 0.0428
121 CARDIOTOXICITY 380 0.0426
122 LEFT VENTRICULAR DYSFUNCTION 284 0.0424
123 SECOND PRIMARY MALIGNANCY 342 0.0411
124 TUMOUR PAIN 54 0.0410
125 NEUTROPENIA 5567 0.0409
126 PALMAR ERYTHEMA 47 0.0408
127 RADIOTHERAPY 78 0.0408
128 ENTEROCOLITIS 232 0.0401
129 LEUKOPENIA 2009 0.0401
130 EMBOLISM 332 0.0399
131 SUBILEUS 83 0.0398
132 CORTISOL DECREASED 45 0.0394
133 HYPOPROTEINAEMIA 74 0.0390
134 METASTASES TO SPINE 131 0.0389
135 EJECTION FRACTION DECREASED 603 0.0388
136 NEOPLASM RECURRENCE 131 0.0386
137 DYSAESTHESIA 118 0.0385
138 HEPATITIS B REACTIVATION 122 0.0384
139 ADRENAL INSUFFICIENCY 465 0.0383
140 JUGULAR VEIN THROMBOSIS 68 0.0382
141 OTOTOXICITY 70 0.0378
142 PELVIC ABSCESS 43 0.0374
143 SECONDARY ADRENOCORTICAL INSUFFICIENCY 56 0.0371
144 MYELODYSPLASTIC SYNDROME 531 0.0367
145 HEPATIC CYTOLYSIS 464 0.0364
146 SEROMA 46 0.0362
147 FEBRILE BONE MARROW APLASIA 153 0.0360
148 INTERSTITIAL LUNG DISEASE 1743 0.0360
149 BREAST NEOPLASM 37 0.0359
150 BONE MARROW TOXICITY 42 0.0354
151 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 826 0.0354
152 LARGE INTESTINE PERFORATION 245 0.0352
153 ACQUIRED GENE MUTATION 46 0.0351
154 NEOPLASM PROGRESSION 1215 0.0349
155 MACULAR OEDEMA 191 0.0340
156 BONE MARROW FAILURE 689 0.0339
157 BICYTOPENIA 66 0.0336
158 DISEASE PROGRESSION 3940 0.0333
159 PARONYCHIA 146 0.0332
160 STRESS CARDIOMYOPATHY 193 0.0332
161 METASTASIS 236 0.0330
162 HYPERAEMIA 65 0.0330
163 HYPOTHALAMO-PITUITARY DISORDER 48 0.0329
164 METASTATIC NEOPLASM 142 0.0329
165 TYPE I HYPERSENSITIVITY 114 0.0324
166 OXYGEN THERAPY 53 0.0322
167 PROTEINURIA 611 0.0321
168 THROMBOTIC MICROANGIOPATHY 313 0.0321
169 MYOCARDITIS 368 0.0321
170 LIVER ABSCESS 104 0.0320
171 PERIPHERAL SENSORIMOTOR NEUROPATHY 40 0.0318
172 HYPOALBUMINAEMIA 247 0.0317
173 ENCEPHALITIS AUTOIMMUNE 41 0.0312
174 LUNG ADENOCARCINOMA 93 0.0309
175 HYPOMAGNESAEMIA 430 0.0309
176 PNEUMOCYSTIS JIROVECII PNEUMONIA 309 0.0307
177 HAEMOLYTIC URAEMIC SYNDROME 71 0.0306
178 HYPERPYREXIA 128 0.0302
179 LUNG ABSCESS 63 0.0300
180 MASTECTOMY 52 0.0297
181 VENA CAVA THROMBOSIS 49 0.0295
182 SYSTEMIC INFECTION 48 0.0289
183 GASTRIC PERFORATION 78 0.0286
184 PSEUDOMEMBRANOUS COLITIS 63 0.0282
185 KOUNIS SYNDROME 64 0.0282
186 CANCER PAIN 72 0.0281
187 NAIL DISORDER 246 0.0281
188 ADENOCARCINOMA 63 0.0281
189 THROMBOCYTOPENIA 3144 0.0281
190 TUMOUR MARKER INCREASED 132 0.0275
191 HYDRONEPHROSIS 204 0.0272
192 ASCITES 797 0.0271
193 OVARIAN CANCER 249 0.0270
194 PNEUMATOSIS INTESTINALIS 77 0.0270
195 NEPHRITIS 90 0.0269
196 LYMPHOEDEMA 186 0.0269
197 PULMONARY SEPSIS 39 0.0268
198 ATELECTASIS 259 0.0268
199 GENE MUTATION 53 0.0268
200 ANAPHYLACTIC SHOCK 690 0.0267
201 EMPYEMA 53 0.0266
202 BONE LESION 96 0.0266
203 BILIARY DILATATION 39 0.0265
204 NEUTROPHIL COUNT ABNORMAL 75 0.0265
205 ERYTHEMA MULTIFORME 247 0.0265
206 BREAST DISORDER 54 0.0264
207 OSTEOLYSIS 54 0.0264
208 ASPARTATE AMINOTRANSFERASE ABNORMAL 40 0.0262
209 VOCAL CORD PARALYSIS 47 0.0262
210 OSTEOSCLEROSIS 41 0.0260
211 LARYNGOSPASM 70 0.0260
212 PERFORMANCE STATUS DECREASED 121 0.0259
213 HEPATIC LESION 112 0.0259
214 OESOPHAGITIS 282 0.0258
215 RECURRENT CANCER 105 0.0257
216 URINARY TRACT OBSTRUCTION 61 0.0257
217 VENOUS THROMBOSIS LIMB 53 0.0257
218 ANAEMIA 4893 0.0256
219 PERIODONTITIS 55 0.0254
220 HEPATIC FUNCTION ABNORMAL 945 0.0253
221 HYPOTHYROIDISM 808 0.0253
222 CACHEXIA 129 0.0250
223 ORGANISING PNEUMONIA 124 0.0250
224 LYMPHOPENIA 351 0.0248
225 DISSEMINATED INTRAVASCULAR COAGULATION 349 0.0248
226 NAIL DISCOLOURATION 97 0.0247
227 EMBOLISM VENOUS 74 0.0244
228 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 183 0.0244
229 PNEUMOTHORAX 385 0.0243
230 CARCINOEMBRYONIC ANTIGEN INCREASED 47 0.0242
231 AUTOIMMUNE HAEMOLYTIC ANAEMIA 83 0.0242
232 ADRENOCORTICAL INSUFFICIENCY ACUTE 47 0.0241
233 TUMOUR LYSIS SYNDROME 211 0.0240
234 AZOTAEMIA 95 0.0238
235 SUFFOCATION FEELING 59 0.0238
236 JAUNDICE CHOLESTATIC 84 0.0238
237 ILEUS 295 0.0237
238 ALANINE AMINOTRANSFERASE ABNORMAL 50 0.0237
239 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 225 0.0235
240 HYPOXIA 830 0.0235
241 DERMATITIS ACNEIFORM 142 0.0233
242 IMMUNE-MEDIATED MYOSITIS 64 0.0232
243 IMMUNE THROMBOCYTOPENIA 106 0.0231
244 OLIGOHYDRAMNIOS 77 0.0231
245 WOUND DEHISCENCE 78 0.0231
246 INTESTINAL PERFORATION 259 0.0231
247 PORTAL HYPERTENSION 71 0.0230
248 ADRENAL DISORDER 44 0.0229
249 BRONCHOSPASM 321 0.0225
250 PANCYTOPENIA 1257 0.0225
251 VENOUS THROMBOSIS 88 0.0224
252 CELL DEATH 44 0.0222
253 HYPOKALAEMIA 1014 0.0219
254 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 39 0.0219
255 MYOSITIS 195 0.0217
256 TYPE 1 DIABETES MELLITUS 129 0.0214
257 COLITIS 810 0.0213
258 ANAPHYLACTOID REACTION 87 0.0211
259 DYSPNOEA AT REST 61 0.0210
260 RASH MACULO-PAPULAR 465 0.0209
261 HYPERTHYROIDISM 299 0.0206
262 CYSTITIS HAEMORRHAGIC 83 0.0206
263 PULSE ABSENT 97 0.0204
264 CATHETER SITE INFECTION 77 0.0203
265 INFUSION RELATED REACTION 1338 0.0202
266 EXPOSED BONE IN JAW 43 0.0198
267 SCLERODERMA 72 0.0198
268 DERMATOMYOSITIS 50 0.0197
269 ABDOMINAL INFECTION 50 0.0196
270 GASTROINTESTINAL NECROSIS 57 0.0195
271 PLEURAL EFFUSION 1186 0.0195
272 SUSPECTED OFF LABEL USE 88 0.0195
273 SMALL INTESTINAL OBSTRUCTION 239 0.0194
274 HEPATOTOXICITY 432 0.0194
275 ESCHERICHIA BACTERAEMIA 45 0.0191
276 ARTERIAL THROMBOSIS 37 0.0191
277 TOXIC SKIN ERUPTION 187 0.0185
278 RHINALGIA 51 0.0185
279 SEPTIC SHOCK 806 0.0185
280 FAILURE TO THRIVE 96 0.0185
281 TRANSAMINASES INCREASED 409 0.0184
282 ESCHERICHIA SEPSIS 53 0.0183
283 CEREBRAL ISCHAEMIA 94 0.0182
284 HYPERBILIRUBINAEMIA 189 0.0182
285 CARDIOMYOPATHY 269 0.0182
286 ENDOMETRIAL CANCER 40 0.0182
287 GUILLAIN-BARRE SYNDROME 87 0.0180
288 ACUTE RESPIRATORY DISTRESS SYNDROME 316 0.0178
289 ENTERITIS 114 0.0178
290 LYMPHOCYTE COUNT DECREASED 312 0.0176
291 CYTOPENIA 216 0.0176
292 MIXED LIVER INJURY 53 0.0176
293 DRUG ERUPTION 312 0.0176
294 WHITE BLOOD CELL COUNT DECREASED 1899 0.0175
295 TROPONIN INCREASED 132 0.0173
296 PORTAL VEIN THROMBOSIS 56 0.0173
297 CARDIAC FAILURE ACUTE 114 0.0171
298 AUTOIMMUNE HEPATITIS 119 0.0171
299 HYPOCALCAEMIA 322 0.0170
300 CARBOHYDRATE ANTIGEN 125 INCREASED 58 0.0170
301 DERMATITIS BULLOUS 123 0.0170
302 PERICARDIAL EFFUSION 391 0.0169
303 DEVICE RELATED INFECTION 260 0.0169
304 ENCEPHALITIS 116 0.0168
305 VASCULAR DEVICE INFECTION 76 0.0167
306 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 172 0.0167
307 CYANOSIS 262 0.0166
308 STOMATITIS 1008 0.0166
309 AGRANULOCYTOSIS 306 0.0164
310 HAEMOPTYSIS 458 0.0164
311 FLUSHING 1664 0.0164
312 INTESTINAL ISCHAEMIA 90 0.0163
313 NEUTROPHIL COUNT INCREASED 167 0.0163
314 HEPATIC FAILURE 488 0.0162
315 OXYGEN SATURATION DECREASED 906 0.0161
316 METASTATIC MALIGNANT MELANOMA 37 0.0161
317 PROTEIN TOTAL DECREASED 60 0.0159
318 GENERAL PHYSICAL HEALTH DETERIORATION 1842 0.0159
319 NEPHROTIC SYNDROME 109 0.0159
320 THROMBOTIC THROMBOCYTOPENIC PURPURA 56 0.0159
321 THROMBOCYTOSIS 58 0.0158
322 ASPARTATE AMINOTRANSFERASE INCREASED 840 0.0158
323 PATHOLOGICAL FRACTURE 80 0.0157
324 HYPERTRIGLYCERIDAEMIA 92 0.0157
325 HYPONATRAEMIA 881 0.0156
326 GRANULOCYTOPENIA 89 0.0156
327 PLATELET COUNT DECREASED 1659 0.0155
328 LUNG OPACITY 41 0.0155
329 KERATITIS 47 0.0154
330 FOETAL GROWTH RESTRICTION 94 0.0154
331 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 41 0.0154
332 ALANINE AMINOTRANSFERASE INCREASED 943 0.0153
333 EXTRAVASATION 63 0.0153
334 RENAL TUBULAR DISORDER 43 0.0153
335 HEPATITIS 391 0.0153
336 TOXIC EPIDERMAL NECROLYSIS 231 0.0152
337 MULTIPLE-DRUG RESISTANCE 47 0.0151
338 OESOPHAGEAL STENOSIS 43 0.0151
339 ONYCHOMADESIS 63 0.0150
340 CYTOKINE RELEASE SYNDROME 301 0.0150
341 LUNG INFILTRATION 132 0.0149
342 THROMBOPHLEBITIS 52 0.0148
343 HYPERTENSIVE CRISIS 165 0.0148
344 PYELONEPHRITIS 128 0.0148
345 BACTERAEMIA 175 0.0147
346 UROSEPSIS 136 0.0147
347 ARTERIOSPASM CORONARY 59 0.0147
348 OSTEONECROSIS OF JAW 363 0.0147
349 AUTOIMMUNE THYROIDITIS 55 0.0145
350 HEPATITIS FULMINANT 43 0.0145
351 DRUG RESISTANCE 372 0.0145
352 BLOOD BILIRUBIN INCREASED 387 0.0143
353 PULMONARY HAEMORRHAGE 111 0.0142
354 HYPOVOLAEMIA 83 0.0142
355 BLOOD ALKALINE PHOSPHATASE INCREASED 352 0.0142
356 ANAPHYLACTIC REACTION 783 0.0142
357 HYPERTHERMIA 108 0.0141
358 HYPOPHOSPHATAEMIA 104 0.0141
359 PNEUMONIA BACTERIAL 128 0.0139
360 COLITIS ISCHAEMIC 94 0.0139
361 CONGESTIVE CARDIOMYOPATHY 58 0.0139
362 SEPSIS 1552 0.0139
363 NON-CARDIAC CHEST PAIN 44 0.0139
364 DRUG TOLERANCE DECREASED 39 0.0139
365 TYPE IV HYPERSENSITIVITY REACTION 38 0.0139
366 ACUTE LYMPHOCYTIC LEUKAEMIA 39 0.0138
367 CLOSTRIDIUM DIFFICILE COLITIS 146 0.0138
368 EPISTAXIS 1027 0.0137
369 HEPATITIS ACUTE 89 0.0137
370 BLOOD MAGNESIUM DECREASED 118 0.0137
371 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 52 0.0136
372 LUNG CONSOLIDATION 38 0.0136
373 BONE MARROW DISORDER 41 0.0136
374 CERVIX CARCINOMA 53 0.0136
375 GAMMA-GLUTAMYLTRANSFERASE INCREASED 298 0.0134
376 ODYNOPHAGIA 80 0.0134
377 LEFT VENTRICULAR FAILURE 46 0.0133
378 DIASTOLIC DYSFUNCTION 41 0.0133
379 ILEUS PARALYTIC 59 0.0132
380 ELECTROLYTE IMBALANCE 152 0.0131
381 OESOPHAGEAL CANDIDIASIS 52 0.0130
382 CHEST DISCOMFORT 1333 0.0130
383 RENAL FAILURE CHRONIC 99 0.0129
384 ENDOCARDITIS 66 0.0129
385 SUPRAVENTRICULAR TACHYCARDIA 123 0.0128
386 PANCREATIC CARCINOMA 371 0.0128
387 AMYLASE INCREASED 47 0.0127
388 CHOLESTASIS 244 0.0127
389 CHOLECYSTITIS 151 0.0127
390 FIBRIN D DIMER INCREASED 45 0.0126
391 ACUTE PULMONARY OEDEMA 71 0.0126
392 CARDIAC TAMPONADE 60 0.0126
393 BLOOD PRESSURE SYSTOLIC DECREASED 57 0.0125
394 HYPOVOLAEMIC SHOCK 60 0.0125
395 PULMONARY EMBOLISM 1188 0.0125
396 NEPHROPATHY TOXIC 140 0.0125
397 DISEASE RECURRENCE 591 0.0124
398 ACUTE HEPATIC FAILURE 169 0.0124
399 RESPIRATORY FAILURE 885 0.0121
400 FISTULA 136 0.0121
401 HEPATIC CYST 41 0.0121
402 DUODENAL ULCER 85 0.0120
403 DRUG-INDUCED LIVER INJURY 378 0.0120
404 LIVER INJURY 295 0.0120
405 TUBULOINTERSTITIAL NEPHRITIS 225 0.0120
406 ABDOMINAL ABSCESS 53 0.0120
407 HEPATIC NEOPLASM 39 0.0119
408 ERYSIPELAS 60 0.0119
409 HYPERURICAEMIA 49 0.0119
410 ATRIAL FLUTTER 94 0.0118
411 LEUKOCYTOSIS 213 0.0118
412 HAEMOLYTIC ANAEMIA 104 0.0116
413 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 90 0.0116
414 PERITONITIS 239 0.0115
415 SUDDEN DEATH 122 0.0115
416 PYREXIA 3987 0.0115
417 SINUS TACHYCARDIA 163 0.0115
418 GENERALISED OEDEMA 142 0.0115
419 HICCUPS 93 0.0113
420 PERIPHERAL ISCHAEMIA 46 0.0113
421 MALNUTRITION 126 0.0113
422 TACHYPNOEA 153 0.0112
423 UNRESPONSIVE TO STIMULI 288 0.0111
424 FEELING HOT 683 0.0111
425 BLOOD ALBUMIN DECREASED 88 0.0111
426 ACUTE RESPIRATORY FAILURE 213 0.0111
427 ESCHERICHIA URINARY TRACT INFECTION 47 0.0110
428 HAEMOGLOBIN ABNORMAL 71 0.0110
429 LUNG INFECTION 171 0.0110
430 HYPERGLYCAEMIA 401 0.0110
431 BLOOD PHOSPHORUS DECREASED 40 0.0109
432 TACHYCARDIA 970 0.0109
433 DEHYDRATION 1456 0.0109
434 ORAL CANDIDIASIS 143 0.0108
435 PAPILLOEDEMA 49 0.0108
436 CARDIAC FAILURE 868 0.0108
437 THROAT TIGHTNESS 290 0.0107
438 LARYNGEAL OEDEMA 66 0.0107
439 ERYTHEMA 2195 0.0107
440 DERMATITIS EXFOLIATIVE 53 0.0106
441 EPIGASTRIC DISCOMFORT 41 0.0105
442 BLEPHARITIS 42 0.0105
443 ESCHERICHIA INFECTION 86 0.0104
444 C-REACTIVE PROTEIN INCREASED 378 0.0104
445 MULTIPLE ORGAN DYSFUNCTION SYNDROME 294 0.0104
446 STAPHYLOCOCCAL BACTERAEMIA 45 0.0103
447 DECREASED APPETITE 2400 0.0103
448 SHOCK HAEMORRHAGIC 84 0.0103
449 SKIN NECROSIS 53 0.0102
450 HYPERCALCAEMIA 126 0.0102
451 LEUKOENCEPHALOPATHY 38 0.0102
452 LOW BIRTH WEIGHT BABY 81 0.0102
453 AORTIC DISSECTION 42 0.0101
454 KLEBSIELLA INFECTION 51 0.0101
455 PURULENT DISCHARGE 43 0.0101
456 NECROSIS 56 0.0101
457 MENINGITIS 67 0.0100
458 BONE PAIN 587 0.0100
459 PULMONARY MASS 149 0.0100
460 RESPIRATORY DISTRESS 276 0.0100
461 IMMUNOSUPPRESSION 88 0.0100
462 SHOCK 228 0.0099
463 DEEP VEIN THROMBOSIS 644 0.0099
464 HEPATOCELLULAR INJURY 139 0.0098
465 ACUTE CORONARY SYNDROME 81 0.0098
466 MYOCARDIAL ISCHAEMIA 110 0.0097
467 DERMATITIS 202 0.0096
468 ALOPECIA 1890 0.0096
469 SKIN REACTION 135 0.0096
470 CIRCULATORY COLLAPSE 163 0.0096
471 HYPOPHAGIA 244 0.0095
472 PULMONARY FIBROSIS 182 0.0095
473 CEREBRAL INFARCTION 231 0.0094
474 PULMONARY ALVEOLAR HAEMORRHAGE 53 0.0094
475 BUNDLE BRANCH BLOCK LEFT 40 0.0094
476 UPPER GASTROINTESTINAL HAEMORRHAGE 158 0.0094
477 HYPERTENSION 1982 0.0093
478 ISCHAEMIA 43 0.0093
479 GINGIVITIS 50 0.0093
480 SKIN DISORDER 307 0.0092
481 DYSPNOEA 5199 0.0092
482 PHLEBITIS 47 0.0092
483 ACUTE KIDNEY INJURY 1402 0.0092
484 BLOOD LACTATE DEHYDROGENASE INCREASED 145 0.0091
485 MITRAL VALVE INCOMPETENCE 103 0.0091
486 LOCALISED OEDEMA 42 0.0091
487 SARCOIDOSIS 43 0.0090
488 BLOOD THYROID STIMULATING HORMONE DECREASED 41 0.0090
489 LYMPHADENOPATHY 319 0.0090
490 CHOLECYSTITIS ACUTE 51 0.0090
491 BLOOD DISORDER 72 0.0090
492 CARDIO-RESPIRATORY ARREST 374 0.0089
493 STAPHYLOCOCCAL SEPSIS 44 0.0089
494 MENINGITIS ASEPTIC 40 0.0089
495 AFFECTIVE DISORDER 70 0.0089
496 APHTHOUS ULCER 69 0.0089
497 INTESTINAL OBSTRUCTION 333 0.0088
498 HAEMATOCRIT DECREASED 175 0.0088
499 ABDOMINAL PAIN 2048 0.0088
500 ALTERED STATE OF CONSCIOUSNESS 190 0.0088
501 CELLULITIS 440 0.0087
502 FAECALOMA 47 0.0086
503 HYPERKALAEMIA 298 0.0085
504 COLITIS MICROSCOPIC 40 0.0084
505 HAEMOGLOBIN DECREASED 866 0.0084
506 HYPERNATRAEMIA 42 0.0084
507 PRESYNCOPE 204 0.0084
508 SKIN INFECTION 94 0.0084
509 FACE OEDEMA 141 0.0084
510 BRONCHIECTASIS 56 0.0083
511 LUNG DISORDER 407 0.0083
512 VOMITING 3901 0.0083
513 HYPOTENSION 1660 0.0083
514 PERONEAL NERVE PALSY 47 0.0083
515 APLASTIC ANAEMIA 43 0.0082
516 DIARRHOEA 5271 0.0082
517 PNEUMONIA ASPIRATION 204 0.0082
518 RENAL TUBULAR NECROSIS 80 0.0081
519 FACIAL PARALYSIS 69 0.0081
520 METABOLIC DISORDER 47 0.0081
521 ASTHENIA 3041 0.0081
522 PEMPHIGOID 61 0.0081
523 HYPERSENSITIVITY 1494 0.0080
524 DYSPNOEA EXERTIONAL 302 0.0080
525 ATAXIA 95 0.0080
526 DECUBITUS ULCER 65 0.0080
527 PLEURISY 47 0.0079
528 INFLAMMATORY MARKER INCREASED 39 0.0079
529 BLOOD PRESSURE DIASTOLIC DECREASED 58 0.0078
530 TASTE DISORDER 159 0.0078
531 BLOOD UREA INCREASED 131 0.0078
532 BLOOD CREATININE INCREASED 510 0.0078
533 JAUNDICE 210 0.0078
534 ENCEPHALOPATHY 191 0.0078
535 HYDROCEPHALUS 42 0.0077
536 DIARRHOEA HAEMORRHAGIC 72 0.0077
537 STEVENS-JOHNSON SYNDROME 170 0.0076
538 BACK PAIN 1776 0.0076
539 DERMATITIS ALLERGIC 96 0.0076
540 HAEMATURIA 260 0.0076
541 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 38 0.0075
542 BLOOD THYROID STIMULATING HORMONE INCREASED 69 0.0075
543 MUSCULOSKELETAL CHEST PAIN 116 0.0075
544 LIVER DISORDER 332 0.0075
545 MYASTHENIA GRAVIS 60 0.0074
546 OEDEMA PERIPHERAL 904 0.0074
547 PSYCHOLOGICAL TRAUMA 64 0.0074
548 ISCHAEMIC STROKE 132 0.0074
549 NEUTROPHILIA 42 0.0074
550 SPINAL PAIN 86 0.0073
551 RENAL IMPAIRMENT 616 0.0073
552 CONCOMITANT DISEASE AGGRAVATED 45 0.0073
553 GINGIVAL PAIN 58 0.0073
554 CENTRAL NERVOUS SYSTEM LESION 100 0.0073
555 BODY TEMPERATURE INCREASED 148 0.0072
556 BLOOD SODIUM DECREASED 136 0.0072
557 POLYARTHRITIS 38 0.0072
558 CONSTIPATION 1570 0.0072
559 MOUTH ULCERATION 151 0.0072
560 CARDIOGENIC SHOCK 102 0.0071
561 NAUSEA 5619 0.0071
562 BREAST CANCER 660 0.0071
563 TRICUSPID VALVE INCOMPETENCE 56 0.0070
564 SENSORY DISTURBANCE 113 0.0070
565 HEPATOMEGALY 69 0.0070
566 PNEUMONIA 2269 0.0070
567 RASH PUSTULAR 51 0.0070
568 DYSPHAGIA 656 0.0069
569 NEURALGIA 168 0.0069
570 CHOKING SENSATION 38 0.0069
571 SPINAL OSTEOARTHRITIS 60 0.0068
572 ONYCHOCLASIS 47 0.0068
573 HEPATIC STEATOSIS 127 0.0068
574 PANCREATITIS ACUTE 153 0.0068
575 HAIR DISORDER 56 0.0068
576 GASTROINTESTINAL DISORDER 607 0.0068
577 SPINAL COMPRESSION FRACTURE 56 0.0068
578 SYNCOPE 677 0.0068
579 HEPATIC CIRRHOSIS 127 0.0068
580 OEDEMA 366 0.0067
581 WHITE BLOOD CELL COUNT ABNORMAL 43 0.0067
582 GINGIVAL BLEEDING 92 0.0067
583 ASPERGILLUS INFECTION 44 0.0067
584 NEOPLASM 77 0.0067
585 RESPIRATORY TRACT INFECTION 174 0.0067
586 PARAESTHESIA 1048 0.0067
587 LIPASE INCREASED 51 0.0066
588 INFECTION 953 0.0066
589 SENSORY LOSS 53 0.0066
590 SKIN ULCER 169 0.0065
591 PROTHROMBIN TIME PROLONGED 39 0.0065
592 SKIN HYPERPIGMENTATION 56 0.0065
593 VENTRICULAR FIBRILLATION 72 0.0065
594 PREMATURE DELIVERY 103 0.0065
595 GASTRITIS 170 0.0065
596 ANOREXIA 83 0.0064
597 CARDIAC ARREST 531 0.0064
598 DEFAECATION URGENCY 45 0.0064
599 OROPHARYNGEAL DISCOMFORT 58 0.0064
600 PROCTALGIA 41 0.0064
601 POST PROCEDURAL COMPLICATION 122 0.0063
602 CHILLS 743 0.0063
603 ATRIAL FIBRILLATION 615 0.0063
604 LIVER FUNCTION TEST INCREASED 135 0.0063
605 PREMATURE BABY 189 0.0063
606 ORAL DISORDER 46 0.0063
607 GASTRIC HAEMORRHAGE 72 0.0063
608 CHEST PAIN 1158 0.0062
609 DEPRESSED LEVEL OF CONSCIOUSNESS 245 0.0062
610 BRONCHOPULMONARY ASPERGILLOSIS 48 0.0062
611 PULMONARY OEDEMA 277 0.0062
612 PSEUDOMONAS INFECTION 53 0.0062
613 OFF LABEL USE 5388 0.0061
614 GASTROENTERITIS 89 0.0061
615 ORTHOSTATIC HYPOTENSION 106 0.0061
616 IMPAIRED HEALING 199 0.0061
617 RED BLOOD CELL COUNT DECREASED 173 0.0060
618 RENAL CYST 48 0.0060
619 THYROID DISORDER 93 0.0060
620 HAEMATEMESIS 152 0.0060
621 DYSGEUSIA 445 0.0060
622 VENTRICULAR EXTRASYSTOLES 62 0.0060
623 WOUND INFECTION 65 0.0059
624 VASCULITIS 69 0.0059
625 HAEMORRHAGIC STROKE 46 0.0059
626 ASPHYXIA 48 0.0059
627 DRUG TOXICITY 80 0.0059
628 CYSTITIS 187 0.0059
629 MADAROSIS 68 0.0059
630 ATRIOVENTRICULAR BLOCK COMPLETE 39 0.0058
631 CLOSTRIDIUM DIFFICILE INFECTION 127 0.0058
632 RASH 2527 0.0058
633 BLOOD CALCIUM DECREASED 65 0.0058
634 BRAIN OEDEMA 73 0.0058
635 HAEMODYNAMIC INSTABILITY 44 0.0058
636 GENERAL PHYSICAL CONDITION ABNORMAL 39 0.0057
637 EMPHYSEMA 58 0.0057
638 BLOOD PRESSURE DECREASED 382 0.0057
639 URINARY TRACT INFECTION 975 0.0057
640 DYSURIA 210 0.0057
641 SKIN MASS 38 0.0057
642 EYELID OEDEMA 66 0.0057
643 COLD SWEAT 100 0.0057
644 FLANK PAIN 53 0.0056
645 RESPIRATORY RATE INCREASED 50 0.0056
646 BREAST PAIN 60 0.0056
647 PARAESTHESIA ORAL 81 0.0056
648 HEPATIC ENCEPHALOPATHY 52 0.0056
649 THERAPY NON-RESPONDER 250 0.0056
650 MYOPATHY 48 0.0056
651 WHITE BLOOD CELL COUNT INCREASED 213 0.0055
652 BONE DISORDER 101 0.0055
653 FATIGUE 4314 0.0055
654 HYPERHIDROSIS 709 0.0055
655 DELIRIUM 191 0.0055
656 MULTI-ORGAN FAILURE 95 0.0055
657 MENTAL STATUS CHANGES 152 0.0055
658 GASTRIC ULCER 104 0.0055
659 LOSS OF CONSCIOUSNESS 701 0.0055
660 OSTEOMYELITIS 99 0.0055
661 PRODUCT USE IN UNAPPROVED INDICATION 1349 0.0054
662 PALLOR 148 0.0054
663 EYE MOVEMENT DISORDER 37 0.0054
664 ASPIRATION 59 0.0054
665 HOT FLUSH 404 0.0054
666 RECTAL HAEMORRHAGE 230 0.0053
667 SCHIZOPHRENIA 65 0.0053
668 CONJUNCTIVITIS 99 0.0053
669 RHINITIS 43 0.0053
670 LIVER FUNCTION TEST ABNORMAL 155 0.0053
671 DIABETIC KETOACIDOSIS 128 0.0053
672 COUGH 1490 0.0053
673 URINARY INCONTINENCE 157 0.0053
674 LOWER GASTROINTESTINAL HAEMORRHAGE 39 0.0053
675 DEATH 4513 0.0052
676 HYPOAESTHESIA 783 0.0052
677 MYALGIA 887 0.0052
678 INCONTINENCE 55 0.0052
679 MELAENA 114 0.0052
680 ABSCESS 82 0.0051
681 EPILEPSY 156 0.0051
682 CANDIDA INFECTION 86 0.0051
683 IRON DEFICIENCY ANAEMIA 47 0.0051
684 RENAL FAILURE ACUTE 215 0.0051
685 ACUTE MYOCARDIAL INFARCTION 148 0.0050
686 HYPERAESTHESIA 41 0.0050
687 PETECHIAE 52 0.0050
688 RESPIRATORY SYNCYTIAL VIRUS INFECTION 43 0.0049
689 APPENDICITIS 46 0.0049
690 BLOOD POTASSIUM DECREASED 148 0.0049
691 URINE OUTPUT DECREASED 43 0.0049
692 SUBARACHNOID HAEMORRHAGE 50 0.0049
693 DRUG INTOLERANCE 473 0.0049
694 SQUAMOUS CELL CARCINOMA 46 0.0049
695 COAGULOPATHY 81 0.0049
696 SKIN LESION 132 0.0048
697 GASTROINTESTINAL HAEMORRHAGE 401 0.0048
698 APHASIA 144 0.0048
699 STAPHYLOCOCCAL INFECTION 157 0.0048
700 HAEMATOMA 122 0.0047
701 VERTIGO 281 0.0046
702 CEREBRAL HAEMORRHAGE 164 0.0046
703 BLOOD CALCIUM INCREASED 40 0.0046
704 VISUAL ACUITY REDUCED 151 0.0045
705 PELVIC PAIN 82 0.0045
706 RENAL FAILURE 599 0.0045
707 CARDIOMEGALY 55 0.0045
708 SARS-COV-2 TEST POSITIVE 59 0.0045
709 HAEMORRHOIDS 87 0.0045
710 INTENTIONAL PRODUCT USE ISSUE 390 0.0044
711 OSTEONECROSIS 146 0.0044
712 NO THERAPEUTIC RESPONSE 54 0.0044
713 MUSCULAR WEAKNESS 503 0.0044
714 HAIR COLOUR CHANGES 55 0.0044
715 HAEMORRHAGE INTRACRANIAL 66 0.0044
716 PURPURA 39 0.0044
717 THROMBOSIS 352 0.0044
718 NERVOUS SYSTEM DISORDER 136 0.0044
719 HALLUCINATION, AUDITORY 69 0.0043
720 PHOTOSENSITIVITY REACTION 71 0.0043
721 HEPATIC ENZYME INCREASED 289 0.0042
722 COVID-19 PNEUMONIA 50 0.0042
723 BACTERIAL INFECTION 79 0.0042
724 TOOTH ABSCESS 43 0.0042
725 NODULE 55 0.0042
726 ANGINA PECTORIS 120 0.0042
727 SPLENOMEGALY 49 0.0042
728 TOXICITY TO VARIOUS AGENTS 702 0.0042
729 ORAL PAIN 93 0.0041
730 EYELID PTOSIS 42 0.0041
731 GASTROINTESTINAL INFECTION 37 0.0041
732 DYSPHONIA 241 0.0041
733 RASH ERYTHEMATOUS 196 0.0041
734 BLOOD CREATINE PHOSPHOKINASE INCREASED 118 0.0041
735 TOOTHACHE 74 0.0041
736 PULMONARY HYPERTENSION 85 0.0041
737 BLOOD PRESSURE SYSTOLIC INCREASED 79 0.0040
738 DRY THROAT 41 0.0040
739 LEUKAEMIA 38 0.0040
740 PLATELET COUNT INCREASED 52 0.0040
741 GENERALISED TONIC-CLONIC SEIZURE 66 0.0040
742 ABDOMINAL PAIN LOWER 100 0.0040
743 HYPOTHERMIA 40 0.0039
744 PHARYNGITIS 49 0.0039
745 TOOTH EXTRACTION 49 0.0039
746 RESPIRATORY DISORDER 117 0.0039
747 PRODUCTIVE COUGH 184 0.0039
748 BLOOD PRESSURE ABNORMAL 76 0.0038
749 DIPLOPIA 99 0.0038
750 FRACTURE 72 0.0038
751 ARRHYTHMIA 180 0.0038
752 WEIGHT DECREASED 1051 0.0038
753 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 267 0.0037
754 DRUG INTERACTION 595 0.0037
755 HAIR TEXTURE ABNORMAL 50 0.0037
756 RESPIRATORY ARREST 103 0.0037
757 MALAISE 1635 0.0037
758 UPPER RESPIRATORY TRACT INFECTION 172 0.0037
759 HEMIPARESIS 63 0.0037
760 CARDIOVASCULAR DISORDER 94 0.0037
761 BLOOD TEST ABNORMAL 52 0.0037
762 VENTRICULAR TACHYCARDIA 61 0.0037
763 MASS 51 0.0036
764 TENDERNESS 38 0.0036
765 MOTOR DYSFUNCTION 37 0.0036
766 MUSCULOSKELETAL PAIN 190 0.0036
767 URINARY RETENTION 120 0.0036
768 MICTURITION URGENCY 41 0.0036
769 PERICARDITIS 60 0.0036
770 PERIPHERAL COLDNESS 49 0.0036
771 COGNITIVE DISORDER 164 0.0035
772 FOETAL EXPOSURE DURING PREGNANCY 281 0.0035
773 DENTAL CARIES 38 0.0034
774 ORAL HERPES 67 0.0034
775 INFLAMMATION 177 0.0034
776 PAIN IN JAW 97 0.0034
777 TOOTH INFECTION 45 0.0034
778 LETHARGY 196 0.0034
779 RIB FRACTURE 70 0.0034
780 DYSPEPSIA 333 0.0034
781 PALPITATIONS 396 0.0034
782 CYTOMEGALOVIRUS INFECTION 56 0.0034
783 FEEDING DISORDER 68 0.0033
784 CARDIAC FAILURE CONGESTIVE 265 0.0033
785 ABDOMINAL PAIN UPPER 677 0.0033
786 FULL BLOOD COUNT DECREASED 66 0.0033
787 LOWER RESPIRATORY TRACT INFECTION 148 0.0033
788 DYSARTHRIA 122 0.0032
789 ADVERSE EVENT 298 0.0032
790 ELECTROCARDIOGRAM QT PROLONGED 116 0.0032
791 PRURITUS 1237 0.0032
792 DRY MOUTH 261 0.0032
793 LACRIMATION INCREASED 97 0.0032
794 ECZEMA 168 0.0032
795 HYPERLIPIDAEMIA 38 0.0032
796 DISORIENTATION 126 0.0032
797 CONFUSIONAL STATE 513 0.0032
798 DEAFNESS 83 0.0032
799 METABOLIC ACIDOSIS 101 0.0032
800 SEIZURE 364 0.0031
801 ULCER 50 0.0031
802 ABDOMINAL DISTENSION 328 0.0031
803 PANCREATITIS 166 0.0031
804 EAR PAIN 61 0.0031
805 DEVICE OCCLUSION 44 0.0031
806 HYPOAESTHESIA ORAL 47 0.0031
807 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 170 0.0031
808 RHABDOMYOLYSIS 129 0.0031
809 IMMUNODEFICIENCY 46 0.0031
810 ARTHRALGIA 1276 0.0031
811 THERAPEUTIC RESPONSE DECREASED 186 0.0031
812 INTERNATIONAL NORMALISED RATIO INCREASED 87 0.0030
813 TREATMENT FAILURE 252 0.0030
814 MATERNAL EXPOSURE DURING PREGNANCY 271 0.0030
815 HERPES ZOSTER 173 0.0030
816 BLOOD PRESSURE INCREASED 459 0.0030
817 EXTRAPYRAMIDAL DISORDER 74 0.0030
818 SKIN EXFOLIATION 251 0.0030
819 HAEMORRHAGE 311 0.0030
820 SKIN FISSURES 58 0.0030
821 PULMONARY ARTERIAL HYPERTENSION 43 0.0030
822 WHEEZING 175 0.0029
823 UVEITIS 40 0.0029
824 RASH PRURITIC 159 0.0029
825 EATING DISORDER 62 0.0029
826 MUSCULOSKELETAL DISCOMFORT 50 0.0029
827 NEOPLASM MALIGNANT 192 0.0029
828 HEART RATE INCREASED 285 0.0029
829 RESTLESSNESS 105 0.0029
830 ADVERSE REACTION 38 0.0029
831 DIVERTICULITIS 79 0.0028
832 LUNG NEOPLASM MALIGNANT 117 0.0028
833 PULMONARY CONGESTION 37 0.0028
834 PARALYSIS 40 0.0028
835 CONDITION AGGRAVATED 848 0.0028
836 HAEMATOCHEZIA 153 0.0028
837 HEART RATE DECREASED 95 0.0027
838 OSTEOPENIA 41 0.0027
839 PAIN IN EXTREMITY 792 0.0027
840 DISCOMFORT 164 0.0027
841 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 139 0.0027
842 FEELING COLD 74 0.0027
843 THROAT IRRITATION 119 0.0026
844 ILL-DEFINED DISORDER 161 0.0026
845 BRADYCARDIA 137 0.0026
846 WOUND 72 0.0026
847 DIZZINESS 1282 0.0026
848 EOSINOPHILIA 45 0.0026
849 GASTROOESOPHAGEAL REFLUX DISEASE 204 0.0025
850 EXPOSURE DURING PREGNANCY 157 0.0025
851 TINNITUS 116 0.0025
852 PSYCHOTIC DISORDER 74 0.0025
853 RENAL DISORDER 116 0.0025
854 GASTRIC CANCER 62 0.0024
855 PRODUCT PRESCRIBING ISSUE 53 0.0024
856 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 70 0.0024
857 DRY EYE 119 0.0024
858 RHINORRHOEA 154 0.0024
859 LABORATORY TEST ABNORMAL 70 0.0024
860 BRONCHITIS 174 0.0023
861 VAGINAL HAEMORRHAGE 102 0.0023
862 CHOLELITHIASIS 77 0.0023
863 HEART RATE IRREGULAR 53 0.0023
864 NECK PAIN 129 0.0023
865 PAIN 1412 0.0023
866 SNEEZING 51 0.0023
867 BLISTER 127 0.0023
868 PRODUCT USE ISSUE 424 0.0023
869 RETCHING 48 0.0022
870 COMA 107 0.0022
871 DEPRESSED MOOD 117 0.0022
872 PRESCRIBED UNDERDOSE 44 0.0022
873 COLITIS ULCERATIVE 98 0.0022
874 LIP SWELLING 73 0.0022
875 COVID-19 383 0.0022
876 URTICARIA 365 0.0022
877 AMENORRHOEA 38 0.0022
878 BALANCE DISORDER 186 0.0021
879 HEAD DISCOMFORT 38 0.0021
880 RESTLESS LEGS SYNDROME 39 0.0021
881 NIGHT SWEATS 69 0.0021
882 TREMOR 354 0.0021
883 DRUG INEFFECTIVE 2798 0.0021
884 LOCAL SWELLING 37 0.0021
885 OROPHARYNGEAL PAIN 196 0.0021
886 DIABETES MELLITUS 160 0.0021
887 BLOOD TRIGLYCERIDES INCREASED 37 0.0021
888 PRODUCT PREPARATION ERROR 43 0.0021
889 DRY SKIN 278 0.0021
890 SWELLING FACE 135 0.0021
891 FEMUR FRACTURE 64 0.0021
892 HYPOGLYCAEMIA 100 0.0021
893 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 52 0.0020
894 VISION BLURRED 277 0.0020
895 INTERVERTEBRAL DISC PROTRUSION 44 0.0020
896 CONVULSION 115 0.0020
897 DISTURBANCE IN ATTENTION 107 0.0020
898 FUNGAL INFECTION 66 0.0020
899 CEREBROVASCULAR ACCIDENT 334 0.0020
900 RASH PAPULAR 44 0.0020
901 TRANSIENT ISCHAEMIC ATTACK 66 0.0020
902 CATARACT 116 0.0019
903 POLLAKIURIA 81 0.0019
904 PRURITUS GENERALISED 42 0.0019
905 PAIN OF SKIN 52 0.0019
906 AGITATION 140 0.0019
907 SPINAL FRACTURE 38 0.0019
908 VISUAL IMPAIRMENT 235 0.0019
909 TOOTH DISORDER 42 0.0019
910 LIMB DISCOMFORT 58 0.0019
911 MUSCLE TWITCHING 43 0.0019
912 GAIT DISTURBANCE 353 0.0018
913 SKIN DISCOLOURATION 84 0.0018
914 SWELLING 171 0.0018
915 LACTIC ACIDOSIS 59 0.0018
916 OSTEOARTHRITIS 77 0.0018
917 TYPE 2 DIABETES MELLITUS 61 0.0018
918 MUSCLE SPASMS 331 0.0018
919 ADVERSE DRUG REACTION 162 0.0018
920 DRUG EFFECT INCOMPLETE 64 0.0018
921 HEADACHE 1097 0.0017
922 RASH MACULAR 61 0.0017
923 BLINDNESS 71 0.0017
924 BURNING SENSATION 121 0.0017
925 GAIT INABILITY 57 0.0017
926 SPEECH DISORDER 89 0.0017
927 MYOCARDIAL INFARCTION 296 0.0017
928 AGEUSIA 42 0.0017
929 JOINT STIFFNESS 44 0.0017
930 ANGIOEDEMA 74 0.0017
931 INSOMNIA 434 0.0016
932 ABDOMINAL DISCOMFORT 272 0.0016
933 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 291 0.0016
934 UNDERDOSE 115 0.0016
935 RENAL INJURY 46 0.0015
936 FALL 514 0.0015
937 ANXIETY 438 0.0015
938 SLEEP DISORDER 108 0.0015
939 VIRAL INFECTION 50 0.0015
940 BREAST CANCER FEMALE 40 0.0015
941 CARDIAC DISORDER 139 0.0015
942 INFLUENZA LIKE ILLNESS 122 0.0015
943 FLATULENCE 82 0.0014
944 PERIPHERAL SWELLING 221 0.0014
945 MOVEMENT DISORDER 46 0.0014
946 HYPOACUSIS 60 0.0014
947 DYSSTASIA 40 0.0014
948 NASAL CONGESTION 80 0.0014
949 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 65 0.0014
950 ARTHRITIS 104 0.0013
951 CORONARY ARTERY DISEASE 40 0.0013
952 SOMNOLENCE 264 0.0013
953 SINUSITIS 130 0.0013
954 NASOPHARYNGITIS 233 0.0013
955 HIP FRACTURE 40 0.0012
956 OSTEOPOROSIS 51 0.0012
957 CONTUSION 118 0.0012
958 UNEVALUABLE EVENT 91 0.0012
959 TREATMENT NONCOMPLIANCE 64 0.0012
960 MEDICATION ERROR 65 0.0012
961 MUSCULOSKELETAL STIFFNESS 101 0.0012
962 SURGERY 65 0.0011
963 HALLUCINATION 83 0.0011
964 MEMORY IMPAIRMENT 145 0.0011
965 THERAPY CESSATION 54 0.0011
966 MENTAL DISORDER 45 0.0010
967 DEPRESSION 232 0.0010
968 WEIGHT INCREASED 228 0.0010
969 ASTHMA 115 0.0010
970 AMNESIA 64 0.0010
971 CHRONIC KIDNEY DISEASE 74 0.0010
972 FLUID RETENTION 49 0.0010
973 BLOOD GLUCOSE INCREASED 179 0.0009
974 INJURY 63 0.0009
975 FEELING ABNORMAL 213 0.0009
976 INFLUENZA 97 0.0009
977 OVERDOSE 184 0.0009
978 MOBILITY DECREASED 61 0.0008
979 HOSPITALISATION 124 0.0008
980 ILLNESS 72 0.0007
981 INTENTIONAL PRODUCT MISUSE 61 0.0007
982 SKIN BURNING SENSATION 47 0.0007
983 JOINT SWELLING 76 0.0006
984 THERAPY INTERRUPTED 43 0.0006
985 EMOTIONAL DISTRESS 67 0.0006
986 INCORRECT DOSE ADMINISTERED 120 0.0005
987 PSORIASIS 68 0.0005
988 MIGRAINE 49 0.0005
989 RHEUMATOID ARTHRITIS 57 0.0005
990 NO ADVERSE EVENT 84 0.0005
991 PRODUCT QUALITY ISSUE 45 0.0003
992 PRODUCT DOSE OMISSION ISSUE 80 0.0003
993 INJECTION SITE PAIN 74 0.0002
994 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 42 0.0002